Co-Founder & Executive Chairman, Xing Technologies
Paul worked as a medical oncologist for 25 years, with an emphasis on basic, clinical and translational research applying new technologies to deliver the best available personalised care to patients and their carers. He published extensively in the world’s leading cancer journals including the New England of Medicine, Lancet, Lancet Oncology, Journal of Clinical Oncology amongst others.
After Paul’s initial Medical Oncology training in Sydney at Royal Prince Alfred and Royal North Shore hospitals he moved to the Royal Marsden in London – Europe’s largest cancer hospital. Paul completed his MD in cell death at the Institute of Cancer Research and was appointed as a consultant at Guy’s, King’s and St Thomas’ NHS Trusts in 1999.
In 2002, Paul returned to Australia as Director of Medical Oncology, Mater Adult Hospital and in 2008 Paul transferred across into private practice in Queensland continuing his translational & clinical research. As part of this work he came across the disruptive nanotechnologies being developed in Queensland that could transform patient care.
In 2019, Paul transitioned across from working as a medical oncologist to XING to assist the brilliant team of researchers in bringing the XING vision to patients.